[Form 3] ICL Group Ltd. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ICL Group Ltd. executive Desikan Anantha reported existing stock option holdings in a Form 3. He holds stock options over 545,365 Ordinary Shares at an exercise price of $9.93 per share, fully vested and exercisable, expiring on February 8, 2027.
He also holds stock options over 940,285 Ordinary Shares at an exercise price of $6.03 per share, vesting in three equal annual installments from the April 4, 2024 grant date and expiring on April 4, 2029. The options are held by a Trustee in his name.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Desikan Anantha
Role
EVP, Chief Innov. & Tech Ofcr.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 545,365 shares (Direct)
Footnotes (1)
- The stock options are fully vested and exercisable. The stock options vest in three equal annual installments from the April 4, 2024 grant date. Represents an exercise price of NIS 31.27, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 18.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
Key Figures
Fully vested options: 545,365 underlying shares at $9.93
Partially vesting options: 940,285 underlying shares at $6.03
Total underlying shares: 1,485,650 shares
+2 more
5 metrics
Fully vested options
545,365 underlying shares at $9.93
Stock Options (Right to Buy), expiration February 8, 2027
Partially vesting options
940,285 underlying shares at $6.03
Vest in three annual installments from April 4, 2024; expire April 4, 2029
Total underlying shares
1,485,650 shares
Combined underlying Ordinary Shares for both option grants
NIS 31.27 option price
$9.93 equivalent
Converted using $1.00 = NIS 3.149 as of March 27, 2026
NIS 18.99 option price
$6.03 equivalent
Converted using $1.00 = NIS 3.149 as of March 27, 2026
Key Terms
Stock Options (Right to Buy), Ordinary Shares, vest in three equal annual installments, Bank of Israel representative exchange rate, +1 more
5 terms
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
vest in three equal annual installments financial
"The stock options vest in three equal annual installments from the April 4, 2024 grant date."
Bank of Israel representative exchange rate financial
"converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149"
Trustee financial
"The options are held by a Trustee in the name of the Reporting Person."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.